The team hypothesized that a mucosal immune response to subdoligranulum didolesgii could expand into a whole-body immune response. To test this, the researchers gave mice oral doses of the bacterium and studied their antibody responses and other physical responses. They found that the mice produced antibodies and T cells that attacked the joints, leading to chronic inflammation.
